WHO ICTRP trial
A Randomised, Double-Blind, 52-week, Parallel-Group, Multicentre, Phase IIb…
EUCTR2005-002508-41-HU · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-002508-41-HU |
|---|---|
| Public title | A Randomised, Double-Blind, 52-week, Parallel-Group, Multicentre, Phase IIb Study to Evaluate the Effects of Rosuvastatin 10 mg, Rosuvastatin 40 mg and Atorvastatin 80 mg on Urinary Protein Excretion in Hypercholesterolaemic Non-Diabetic Patients with Moderate Proteinuria PLANET II: Prospective evaLuation of proteinuriA and reNal function in non-diabETic patients with progressive renal disease - PLANET II |
| Scientific title | A Randomised, Double-Blind, 52-week, Parallel-Group, Multicentre, Phase IIb Study to Evaluate the Effects of Rosuvastatin 10 mg, Rosuvastatin 40 mg and Atorvastatin 80 mg on Urinary Protein Excretion in Hypercholesterolaemic Non-Diabetic Patients with Moderate Proteinuria PLANET II: Prospective… |
| Primary sponsor | AstraZeneca AB |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Hungary;Germany;Denmark;Italy |
| Conditions | Male and female, non-diabetic patients aged =18 with moderate proteinuria (baseline urinary protein/creatinine ratio =500 mg/g and =5000 mg/g), hypercholesterolaemia (fasting LDL-C =90 mg/dL (2.33 mmol/L) and receiving current treatment… |
| Interventions | Trade Name: Crestor 5mg Product Name: Crestor 5mg encapsulated tablet Product Code: AZD4522 Pharmaceutical Form: Film-coated tablet INN or Proposed INN: rosuvastatin Other descriptive name: AZD4522 Concentration unit: mg milligram(s)… |
| Registration date | Sep 11, 2005 |
| Target size | 345 |
| Secondary IDs | D3569C00011 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: